Group 1 - The stock market appears complacent regarding long-term macro risks, including potential recessionary impacts from tariffs and signs of strain in the bond market [1] - Emphasis is placed on value stocks over growth stocks in the current market environment [1] - Gary Alexander has extensive experience in technology companies and has been a contributor to Seeking Alpha since 2017, providing insights into industry trends [1]

A financial researcher and avid investor with a keen eye for innovation and disruption, as well as growth buy-outs and value stocks. Keeping an eye on the pace of high tech and early growth companies, I write about current events and the biggest news surrounding the industry, and strive to provide readers with ample research and investment opportunities.Analyst’s Disclosure:I/we have a beneficial long position in the shares of PSEC either through stock ownership, options, or other derivatives. I wrote this ...

Investors looking for stocks in the Banks - Foreign sector might want to consider either Banco Bilbao (BBVA) or DBS Group Holdings Ltd (DBSDY) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy that ...

Core Insights - Investors are evaluating ABM Industries (ABM) and Cintas (CTAS) for potential value investment opportunities [1] - Both companies currently hold a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and an improving earnings outlook [3] Valuation Metrics - ABM has a forward P/E ratio of 13.58, significantly lower than CTAS's forward P/E of 50.75, suggesting ABM may be undervalued [5] - The PEG ratio for ABM is 2.63, while CTAS has a PEG ratio of 3.85, indicating that ABM offers better value relative to its expected earnings growth [5] - ABM's P/B ratio stands at 1.79 compared to CTAS's P/B of 19.53, further supporting the notion that ABM is the superior value option [6] Value Grades - ABM has received a Value grade of B, while CTAS has a Value grade of D, highlighting the relative valuation strength of ABM [6]

Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health (CVS) and Danaher (DHR) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings es ...

Investors interested in Banks - Foreign stocks are likely familiar with KB Financial (KB) and Nu Holdings Ltd. (NU) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with strong earnings estimate rev ...

With a decade at a Big 4 audit firm specializing in the banking, mining, and energy sectors, I bring a strong foundation in finance and strategy. Currently, I serve as the Head of Finance for a leading owner and operator of retail real estate, where I oversee complex financial operations and strategy. I’ve been an active investor in the U.S. stock market for 13 years, starting with my very first paycheck. Over time, my portfolio has evolved to reflect a balanced approach, with a growing focus on value stock ...

Wall Street bulls fought back after a red start on Monday to close slightly green. The upbeat start to the week came despite Moody’s U.S. credit rating downgrade and warnings from JPMorgan chief executive Jamie Dimon about tariff complacency.Tariff negotiations, trade deals, lower inflation, and strong earnings fueled the recent stock market rally. As long as these sturdy foundations remain in place, the market should remain strong in 2025.Still, stocks could use a period of calm and sideways trading follow ...

Back in 2021, Moderna (NASDAQ: MRNA ) shares traded for around $500 per share, so it is amazing to think that at that time, even just 100 shares of this stock would have set you back by about $50,000. However, since then, it seems likeLong-time stock market investor focused on strategic buying opportunities with dividend and value stocks. This investment strategy has resulted in a near 5 star rating on Tipranks.com and over 9,000 followers on Seeking Alpha. Follow me on Twitter for my latest trading ideas: ...

Core Insights - Investors in the Technology Services sector may consider Qifu Technology, Inc. (QFIN) and Symbotic Inc. (SYM) for potential value opportunities [1] Valuation Metrics - QFIN has a forward P/E ratio of 6.38, significantly lower than SYM's forward P/E of 133.59 [5] - The PEG ratio for QFIN is 0.57, indicating a favorable valuation relative to its expected earnings growth, while SYM's PEG ratio is 4.45 [5] - QFIN's P/B ratio stands at 2.10, compared to SYM's P/B of 37.63, suggesting QFIN is more reasonably valued based on its book value [6] Analyst Outlook - QFIN currently holds a Zacks Rank of 1 (Strong Buy), reflecting a positive earnings estimate revision trend, while SYM has a Zacks Rank of 5 (Strong Sell) [3] - The improving earnings outlook for QFIN positions it as a superior value option compared to SYM [7] Value Grades - QFIN has been assigned a Value grade of A, indicating strong undervaluation metrics, whereas SYM has a Value grade of F, suggesting it is overvalued [6]